Shares of Itron, Inc. (NASDAQ:ITRI) have received a consensus rating of “Buy” from the twelve ratings firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $78.14.
Several equities research analysts recently weighed in on ITRI shares. BidaskClub cut Itron from a “strong-buy” rating to a “buy” rating in a research note on Saturday, November 7th. ValuEngine lowered Itron from a “buy” rating to a “hold” rating in a research report on Wednesday, December 23rd. Raymond James lowered Itron from a “strong-buy” rating to an “outperform” rating and lifted their price target for the stock from $78.00 to $110.00 in a research report on Friday, January 8th. Zacks Investment Research raised Itron from a “sell” rating to a “hold” rating and set a $68.00 price target on the stock in a research report on Tuesday, October 6th. Finally, Stephens initiated coverage on Itron in a research report on Thursday, October 15th. They set an “overweight” rating on the stock.
ITRI stock traded down $2.31 during trading on Wednesday, hitting $100.69. 337,492 shares of the company’s stock were exchanged, compared to its average volume of 442,599. The business has a 50-day moving average price of $90.30 and a two-hundred day moving average price of $72.03. The stock has a market capitalization of $4.07 billion, a price-to-earnings ratio of -62.15 and a beta of 1.13. Itron has a 52-week low of $40.48 and a 52-week high of $108.89. The company has a current ratio of 2.30, a quick ratio of 1.95 and a debt-to-equity ratio of 1.65.
In other news, Director Thomas S. Glanville sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, November 23rd. The stock was sold at an average price of $78.36, for a total value of $78,360.00. Following the transaction, the director now owns 9,082 shares of the company’s stock, valued at $711,665.52. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 1.72% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. FMR LLC grew its holdings in Itron by 3.1% during the first quarter. FMR LLC now owns 253,752 shares of the scientific and technical instruments company’s stock worth $11,837,000 after acquiring an additional 7,614 shares during the period. American International Group Inc. boosted its position in Itron by 18.1% during the second quarter. American International Group Inc. now owns 27,954 shares of the scientific and technical instruments company’s stock worth $1,852,000 after purchasing an additional 4,275 shares in the last quarter. Advisor Group Holdings Inc. boosted its position in Itron by 5.4% during the second quarter. Advisor Group Holdings Inc. now owns 3,783 shares of the scientific and technical instruments company’s stock worth $250,000 after purchasing an additional 193 shares in the last quarter. Vanguard Group Inc. boosted its position in Itron by 2.1% during the second quarter. Vanguard Group Inc. now owns 4,110,648 shares of the scientific and technical instruments company’s stock worth $272,332,000 after purchasing an additional 86,433 shares in the last quarter. Finally, Brookfield Asset Management Inc. purchased a new stake in Itron during the second quarter worth $517,000. 86.47% of the stock is currently owned by institutional investors and hedge funds.
Itron, Inc, a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing.
See Also: Stochastic Momentum Index (SMI)
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.